The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of adding plinabulin to pegfilgrastim for the prevention of TAC chemotherapy (Chemo) induced neutropenia (CIN), on patient quality of life (QoL).
 
Ramon Mohanlal
Employment - BeyondSpring Pharmaceuticals
Leadership - BeyondSpring Pharmaceuticals
Stock and Other Ownership Interests - BeyondSpring Pharmaceuticals
 
Yvette Lelorier
Employment - BeyondSpring Pharmaceuticals
Leadership - BeyondSpring Pharmaceuticals
Stock and Other Ownership Interests - BeyondSpring Pharmaceuticals
 
Dominic Mitchell
Consulting or Advisory Role - Abbvie; Agios; Astellas/Agensys; BeyondSpring Pharmaceuticals; Celgene; Ra Pharma; Sage Therapeutics; Sarepta Therapeutics
 
Lan Huang
Employment - BeyondSpring Pharmaceuticals
Leadership - BeyondSpring Pharmaceuticals
Stock and Other Ownership Interests - BeyondSpring Pharmaceuticals
Research Funding - BeyondSpring Pharmaceuticals
Patents, Royalties, Other Intellectual Property - BeyondSpring Pharmaceuticals
Travel, Accommodations, Expenses - BeyondSpring Pharmaceuticals
 
Douglas W. Blayney
Leadership - Artelo Biosciences
Stock and Other Ownership Interests - Artelo Biosciences; Madorra
Consulting or Advisory Role - Creare; Daiichi Sankyo; Embold Health; G1 Therapeutics; Google; Lilly; Merck
Research Funding - BeyondSpring Pharmaceuticals (Inst); Creare (Inst)